
Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0
Part 1: Building a Business Case for Pharma 4.0
October 15, 2025 | Join us for a dynamic virtual event where science meets strategy.
Precise fluid analysis under real-world conditions – accurate temperature control is the key to reliable measurement results.
Elementarhy uses a revolutionary plasma technology, positioning it as a leader in supplying cost-efficient and scalable Membrane Electrode Assemblies (MEAs) to electrolyzer manufacturers.
The Future of the Pharmaceutical Supply Chain
Christene Smith from CHEManager speaks with Christine Bunte, Managing Director of Plastics Europe Deutschland, and Miriam Olivi, President of Women in Plastics Italy.
Chemical customers are willing to pay a premium if their product and service needs are fully met, presenting an opportunity for suppliers to strengthen relationships and generate new value.
The pharmaceutical industry has faced significant margin pressures due to rising energy costs, inflation, and geopolitical disruptions.
Advanced additives for engineering plastics allow compounders to produce materials with properties that significantly exceed previous performance limits.
Trump's tariff policy is a considerable burden and a break with previous practice.
Download this complimentary Expert Insights eBook today!
Aminoverse enables players in the chemical industry to onboard more cost-efficient and sustainable manufacturing by delivering the right enzyme and process.
How designers can help make sustainable materials both attractive and desirable, emphasizing the importance of collaboration among industry professionals to create a new aesthetic language for sustainability.
How pharma & biotech company transformed warehouse capacity planning for strategic growth
Mineral Bisglycinates are currently attracting a great deal of interest. Superior bioavailability and tolerability are the main benefits.
Digital tools increase the efficiency of the chemical industry when combined with proven methods in a targeted manner. Focusing on benefits rather than trends ensures genuine performance improvement.
The pharmaceutical industry is evolving due to new regulations and technological developments. Distributors like Biesterfeld play a central role in supporting manufacturers in their daily operations.
Join virtual conferences and connect with industry leaders worldwide. Discover upcoming events, access credible insights, and expand your professional network—all from home.
Tapping into Future-oriented Synergies of Data Analysis in the Materials Sector
A new study analyzes the material requirements for synthetic kerosene.
Navigating Uncertainty While Unlocking Strategic Opportunities
Download this complimentary how-to guide today!
This Expert Insights eBook hopes to provide scientists with more information on analytical ultracentrifugation (AUC), allowing you to further your research in this field.
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
Digital processes in hazardous areas? Durabook's rugged tablets are ATEX-certified for industrial use.
Consultations on PFAS restriction in the EU are making progress.
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.
Build an AI-ready Data Strategy to Drive Faster Insights, Smarter R&D, and Measurable ROI.
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.
Turn compliance into opportunity—see how data and innovation drive greener processes, lower costs, and sustainable growth in chemical manufacturing.
Enhancing Manufacturing with Faster, Cleaner, High-crystallinity Processes
The bioeconomy offers the chemical industry new pathways to resilience and sustainability—even as economic and political priorities shift
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.
Leading the Way in Pharmaceutical Manufacturing by Fostering an Agile Mindset and an Inclusive Culture.